Ignite Creation Date:
2024-05-06 @ 3:37 AM
Last Modification Date:
2024-10-26 @ 11:36 AM
Study NCT ID:
NCT02339532
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-07
First Post:
2014-12-14
Brief Title:
Neoadjuvant Phase II Trial in Patients With T1c Operable HER2-positive Breast Cancer According to TOP2A Status
Sponsor:
UNICANCER
Organization:
UNICANCER
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06
Completion Date Type:
ESTIMATED
First Submit Date:
2014-12-14
First Submit QC Date:
January 14 2015
Study First Post Date:
2015-01-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-06
Last Update Post Date:
2023-12-07
Last Update Post Date Type:
ACTUAL